Benchmarking Food and Beverage Companies on Obesity Prevention and Nutrition Policies: Evaluation of the BIA-Obesity Australia Initiative, 2017-2019.

Australia Benchmarking Food Companies Nutrition Policy Obesity Prevention Organisational Change

Journal

International journal of health policy and management
ISSN: 2322-5939
Titre abrégé: Int J Health Policy Manag
Pays: Iran
ID NLM: 101619905

Informations de publication

Date de publication:
01 Dec 2021
Historique:
received: 11 03 2020
accepted: 28 07 2020
pubmed: 31 8 2020
medline: 26 3 2022
entrez: 31 8 2020
Statut: epublish

Résumé

The potential role of the food and beverage industry in addressing diet-related disease is much debated, particularly amidst evidence of the targeted strategies, including voluntary self-regulation, used by the industry to influence policy in their favour. At the same time, the need for more comprehensive action to address unhealthy diets has led to a focus on increasing the accountability of different stakeholders. However, there has been limited evaluation of the impact of accountability initiatives on food and beverage company policies and practices. This study evaluated the impact of the BIA-Obesity (Business Impact Assessment - Obesity and population nutrition) Australia Initiative that benchmarked major Australian food and beverage companies on their nutrition-related policies. Evaluation was conducted against the pre-specified logic model for BIA-Obesity and established frameworks for analysing organisational change and corporate political activity. Outcomes evaluated included company engagement with the Initiative, level of media coverage, and impact of the Initiative on company policies and practices based on the perspectives of company representatives. A mixed methods design was employed, including surveys and in-depth interviews with company representatives, and media reports. Approximately half of invited companies participated in the evaluation of the BIA-Obesity Australia Initiative. A number of company representatives indicated that the Initiative had influenced their company's nutrition policies, strategies, and disclosure practices, and had raised their company's awareness of the importance of addressing nutrition issues. Company representatives perceive benchmarking and accountability initiatives as helpful for provoking improvements in nutrition-related policies and practices in their companies. However, the benefits of these initiatives need to be assessed in the context of the broader political and economic environment. Whilst the focus of accountability initiatives, such as BIA-Obesity, are on industry self-regulation efforts, they can also play an important role in drawing attention to the need for increased government regulation.

Sections du résumé

BACKGROUND BACKGROUND
The potential role of the food and beverage industry in addressing diet-related disease is much debated, particularly amidst evidence of the targeted strategies, including voluntary self-regulation, used by the industry to influence policy in their favour. At the same time, the need for more comprehensive action to address unhealthy diets has led to a focus on increasing the accountability of different stakeholders. However, there has been limited evaluation of the impact of accountability initiatives on food and beverage company policies and practices. This study evaluated the impact of the BIA-Obesity (Business Impact Assessment - Obesity and population nutrition) Australia Initiative that benchmarked major Australian food and beverage companies on their nutrition-related policies.
METHODS METHODS
Evaluation was conducted against the pre-specified logic model for BIA-Obesity and established frameworks for analysing organisational change and corporate political activity. Outcomes evaluated included company engagement with the Initiative, level of media coverage, and impact of the Initiative on company policies and practices based on the perspectives of company representatives. A mixed methods design was employed, including surveys and in-depth interviews with company representatives, and media reports.
RESULTS RESULTS
Approximately half of invited companies participated in the evaluation of the BIA-Obesity Australia Initiative. A number of company representatives indicated that the Initiative had influenced their company's nutrition policies, strategies, and disclosure practices, and had raised their company's awareness of the importance of addressing nutrition issues.
CONCLUSION CONCLUSIONS
Company representatives perceive benchmarking and accountability initiatives as helpful for provoking improvements in nutrition-related policies and practices in their companies. However, the benefits of these initiatives need to be assessed in the context of the broader political and economic environment. Whilst the focus of accountability initiatives, such as BIA-Obesity, are on industry self-regulation efforts, they can also play an important role in drawing attention to the need for increased government regulation.

Identifiants

pubmed: 32861228
doi: 10.34172/ijhpm.2020.147
pmc: PMC9309961
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

857-870

Informations de copyright

© 2021 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Références

Public Health Nutr. 2014 Nov;17(11):2467-83
pubmed: 24564894
Global Health. 2016 May 10;12(1):18
pubmed: 27160250
BMJ. 2018 Jun 13;361:k2426
pubmed: 29898890
Obes Rev. 2015 Jul;16(7):519-30
pubmed: 25988272
Lancet. 2015 Jun 20;385(9986):2534-45
pubmed: 25703108
BMC Public Health. 2016 Jul 27;16:651
pubmed: 27465746
Milbank Q. 2009 Mar;87(1):259-94
pubmed: 19298423
Health Policy. 2014 Feb;114(2-3):163-73
pubmed: 24309298
BMC Public Health. 2016 Mar 22;16:283
pubmed: 27004957
Int J Public Health. 2019 Nov;64(8):1147-1157
pubmed: 31230118
Obes Rev. 2013 Dec;14(12):960-74
pubmed: 23845093
Obes Rev. 2013 Oct;14 Suppl 1:38-48
pubmed: 24074209
Curr Obes Rep. 2018 Sep;7(3):211-219
pubmed: 30022469
Aust N Z J Public Health. 2017 Apr;41(2):165-171
pubmed: 28110500
PLoS Med. 2012;9(6):e1001242
pubmed: 22723746
Lancet. 2013 Feb 23;381(9867):670-9
pubmed: 23410611
Obes Rev. 2013 Oct;14 Suppl 1:13-23
pubmed: 24074207
Lancet. 2019 Feb 23;393(10173):791-846
pubmed: 30700377
Lancet. 2015 Oct 31;386(10005):1716-7
pubmed: 26545418
Obes Rev. 2019 Nov;20 Suppl 2:78-89
pubmed: 31317645
J Public Health (Oxf). 2017 Dec 1;39(4):787-792
pubmed: 28158840
Lancet. 2011 Aug 27;378(9793):804-14
pubmed: 21872749
Med J Aust. 2014 Feb 3;200(2):92-5
pubmed: 24484111
Obes Rev. 2013 Oct;14 Suppl 1:1-12
pubmed: 24074206

Auteurs

Ella Robinson (E)

Global Obesity Centre (GLOBE), Institute for Health Transformation, Deakin University, Geelong, VIC, Australia.

Miranda R Blake (MR)

Global Obesity Centre (GLOBE), Institute for Health Transformation, Deakin University, Geelong, VIC, Australia.

Gary Sacks (G)

Global Obesity Centre (GLOBE), Institute for Health Transformation, Deakin University, Geelong, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH